EGFR and glioblastoma: A different study also showed the potential of combination treatment targeting EGFR in recurrent GBM,13 and Gefitinib, which is a first-generation reversible ATP-site competitive EGFR kinase inhibitor, was shown to be effective in treating GBM as well as other cancers.14,15